| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |